Maria Ruderman, a director at Universal Health Services Inc. (NYSE:UHS), has recently engaged in several transactions involving the company's Class B Common Stock. On May 14, 2024, Ruderman acquired 7,500 shares at a price of $138.80 per share, amounting to a total of $1,041,000. On the same day, she disposed of 5,811 shares at $179.15 each, totaling $1,041,040, and sold another 1,689 shares at $179.2938 per share, resulting in $302,827 from the sales.
The series of transactions began with an acquisition of shares, followed by the disposal of a larger number of shares at a higher price. The sales were conducted at a consistent price of $179.2938, as noted in the SEC filing. Additionally, Ruderman was granted 1,097 restricted stock units under the company's 2020 Omnibus Stock and Incentive Plan, which are set to vest on May 15, 2025.
Ruderman's activities also included the exercise of options on 7,500 shares of Class B Common Stock, with the options priced at $138.80 each. These options are part of a vesting schedule that will continue through March 17, 2025.
Investors and market watchers often monitor the trading activities of company insiders for insights into the company's performance and stock valuation. The transactions by Ruderman provide a glimpse into the movement of Universal Health Services' stock within the upper echelons of its leadership.
InvestingPro Insights
Universal Health Services Inc. (NYSE:UHS) has been displaying a robust financial performance, according to recent data from InvestingPro. The company's market capitalization stands at $11.98 billion, reflecting its significant presence in the healthcare industry. Investors may find the P/E ratio of 15.03 particularly interesting, as it suggests that the stock is trading at a reasonable valuation relative to its earnings. When adjusted for the last twelve months as of Q1 2024, the P/E ratio is even slightly lower at 14.68, indicating potential undervaluation.
An InvestingPro Tip to consider is that Universal Health Services has a perfect Piotroski Score of 9, which underscores its strong financial position. Furthermore, the company has been actively managing its stock, with management aggressively buying back shares. This can be a positive signal that the company's leadership is confident in its future prospects.
For those interested in the company's growth metrics, the Revenue Growth for the last twelve months as of Q1 2024 was 7.99%, with a more impressive quarterly revenue growth of 10.85% in Q1 2024. This suggests that Universal Health Services is not only maintaining its financial health but also expanding its operations effectively.
Investors looking for additional insights will find them with InvestingPro, which lists 11 more InvestingPro Tips for UHS, including analysts' upward earnings revisions for the upcoming period and the company's low price volatility. To gain access to these valuable insights, visit https://www.investing.com/pro/UHS and use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.